Richard de Boer

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa et al. · Journal of Clinical Oncology · 2007 · 382 citations

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

Robert E. Coleman, Richard de Boer, Holger Eidtmann et al. · Annals of Oncology · 2012 · 335 citations · Full text

Zoledronic Acid, Final 60-Month Results, Oncology +8

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study

Holger Eidtmann, Richard de Boer, Nigel Bundred et al. · Annals of Oncology · 2010 · 278 citations

Zoledronic Acid, Breast Oncology, Medicine +9

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial

Aaron S. Mansfield, Andrzej Każarnowicz, Nina Karaseva et al. · Annals of Oncology · 2020 · 179 citations · Full text

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa et al. · Clinical Cancer Research · 2008 · 159 citations · Full text